纤维化-4指数可独立预测非酒精性脂肪性肝病患者的主要不良心血管事件
该研究分析81,108例非酒精性脂肪性肝病(NAFLD)、非酒精性脂肪性肝炎(NASH)或NASH高风险(RISK)患者,评估纤维化-4指数(FIB-4)对主要不良心血管事件(MACE)的预测价值。在中位随访3年的67,273例无既往心血管疾病患者中,9,112例(13.5%)发生MACE;校正 established 心血管危险因素后,FIB-4 ≥2.67仍是MACE的最强独立预测因子(aHR 1.80,95%CI 1.61-2.02,P < 0.001)。
要点
- FIB-4 ≥2.67与MACE风险独立相关(aHR 1.80,95%CI 1.61-2.02,P < 0.001)。
- FIB-4 ≥2.67与心肌梗死、不稳定型心绞痛住院、心力衰竭住院、冠状动脉旁路移植术和经皮冠状动脉介入治疗均独立相关。
- FIB-4 ≥2.67是MACE的最强独立预测因子,超越 established 心血管危险因素和基线肝病诊断。
核心结论
- 在NAFLD、NASH或NASH高风险患者的大型真实世界队列中,FIB-4评分是MACE的最强独立预测因子,超越 established 心血管危险因素和基线肝病诊断。
研究设计与样本
- 分析81,108例诊断为NAFLD、NASH或NASH高风险(RISK)患者的数据。
- 感兴趣的结局为主要不良心血管事件(MACE),定义为心肌梗死、因不稳定型心绞痛或心力衰竭住院以及冠状动脉血运重建。
- 在67,273例无既往心血管疾病患者中,中位随访3年。
主要发现
- 患者平均年龄62岁,49.6%为男性。
- 在67,273例无既往心血管疾病患者中,9,112例(13.5%)在中位随访3年期间发生MACE。
- 单因素分析中,FIB-4 ≥2.67是MACE的显著预测因子(HR 1.82,95%CI 1.63-2.04,P < 0.001),且在全部基线组中一致。
- 校正 established 心血管危险因素后,FIB-4 ≥2.67仍是MACE的最强预测因子(aHR 1.80,95%CI 1.61-2.02,P < 0.001)。
- FIB-4 ≥2.67与心肌梗死(aHR 1.46,95%CI 1.25-1.70,P < 0.001)、因不稳定型心绞痛住院(aHR 1.24,95%CI 1.03-1.49,P = 0.025)、因心力衰竭住院(aHR 2.09,95%CI 1.86-2.35,P < 0.001)、冠状动脉旁路移植术(aHR 1.65,95%CI 1.26-2.17,P < 0.001)和经皮冠状动脉介入治疗(aHR 1.72,95%CI 1.21-2.45,P = 0.003)均独立相关。
关键数值与推荐
- FIB-4 ≥2.67是MACE的独立预测因子(aHR 1.80,95%CI 1.61-2.02,P < 0.001)。
- FIB-4 ≥2.67与心肌梗死独立相关(aHR 1.46,95%CI 1.25-1.70,P < 0.001)。
- FIB-4 ≥2.67与因不稳定型心绞痛住院独立相关(aHR 1.24,95%CI 1.03-1.49,P = 0.025)。
- FIB-4 ≥2.67与因心力衰竭住院独立相关(aHR 2.09,95%CI 1.86-2.35,P < 0.001)。
- FIB-4 ≥2.67与冠状动脉旁路移植术(aHR 1.65,95%CI 1.26-2.17,P < 0.001)和经皮冠状动脉介入治疗(aHR 1.72,95%CI 1.21-2.45,P = 0.003)独立相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is closely associated with an increased risk of cardiovascular disease. We aimed to determine whether the fibrosis-4 index (FIB-4) can identify patients with NAFLD at highest risk of cardiovascular events. METHODS: We analyzed data from 81,108 patients with (i) a diagnosis of NAFLD, (ii) nonalcoholic steatohepatitis (NASH), or (iii) at risk (RISK) of NASH. The outcome of interest was major adverse cardiovascular events (MACE) defined by myocardial infarction, hospitalization for unstable angina or heart failure, and coronary revascularization. RESULTS: The mean age was 62 years, and 49.6% were men. Among 67,273 patients without previous cardiovascular disease, 9,112 (13.5%) experienced MACE over median follow-up of 3 years. In univariate analysis, a FIB-4 ≥2.67 was a significant predictor of MACE overall (hazard ratio [HR] 1.82, 95% confidence interval [CI] 1.63-2.04, P < 0.001) and across all baseline groups. After adjusting for established cardiovascular risk factors, FIB-4 ≥2.67 remained the strongest predictor of MACE overall (adjusted HR [aHR] 1.80, 95% CI 1.61-2.02, P < 0.001) and was consistently associated with myocardial infarction (aHR 1.46, 95% CI 1.25-1.70, P < 0.001), hospitalization for unstable angina (aHR 1.24, 95% CI 1.03-1.49, P = 0.025), hospitalization for heart failure (aHR 2.09, 95% CI 1.86-2.35, P < 0.001), coronary artery bypass graft (aHR 1.65, 95% CI 1.26-2.17, P < 0.001), and percutaneous coronary intervention (aHR 1.72, 95% CI 1.21-2.45, P = 0.003). DISCUSSION: In a large, real-world cohort of patients with NAFLD, NASH, or at RISK of NASH, the FIB-4 score was the strongest independent predictor of MACE, beyond established cardiovascular risk factors and baseline liver diagnosis.
引用
- Vieira Barbosa J, Milligan S, Frick A, et al. Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2022. PMID: 35041626. doi:10.14309/ajg.0000000000001606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。